Facilitated By

San Antonio Medical Foundation

News

  • San Antonio wound-care company files for initial public offering

    San Antonio wound-care company Acelity, formerly known as Kinetic ... That year, the company completed the sale of LifeCell Corp., a biomedical ...

  • Houston drug maker targeting cancer tumors gains special FDA approval

    Houston-based Moleculin Biotech Inc., a clinical stage pharmaceutical company, has gained fast-track U.S. Food and Drug Administration approval for ...

  • CSU hires first chief medical research officer

    Prior to joining TMI, Pidcoke also served as chief medical officer of Cellphire Inc., a biotechnology company focused on developing freeze-dried blood ...

  • New Protein Observed To Be Cause For Leukemia

    The findings of the study was published in the journal of Nature Biomedical Engineering. The protein observed can help many different hospitals ...

  • EPS for Celcuity Inc. (CELC) Expected At $-0.22 on May, 13

    ... Studies at the 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with ... “Celcuity Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer Center – Business ...